Mohamad, A.F. et al. 2024. RISK OF KETOACIDOSIS WITH LUSEOGLIFLOZIN IN TYPE 2 DIABETES MELLITUS PATIENTS ON MODERATE DOSE INSULIN THERAPY: A RANDOMISED CONTROL TRIAL. Journal of the ASEAN Federation of Endocrine Societies. 39, S1 (Jul. 2024), 34–35.